Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

IntroductionClinical remission as a multicomponent treatment goal in severe asthma is being explored in clinical practice. This post hoc analysis used data from the REDES study to assess the proportion of patients with severe eosinophilic asthma achieving our multicomponent definitions of clinical r...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Ian Pavord, Frances Gardiner, Liam G. Heaney, Christian Domingo, Robert G. Price, Alison Pullan, John Oppenheimer, Guy Brusselle, Hiroyuki Nagase, Geoffrey Chupp, Emilio Pizzichini, David Bañas-Conejero, Peter Howarth
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2023-04-01
Seri Bilgileri:Frontiers in Immunology
Konular:
severe asthma
remission
clinical outcomes
real-world
eosinophil biology
mepolizumab
Online Erişim:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1150162/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1150162/full

Benzer Materyaller